Showing results (321-330 of 396) with videos related to
Sort By:
Pageof 40
Cell Death Discovery|April 13, 2026
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerabilitySara Franceschi, Mariangela Morelli, Francesca Lessi, et al.Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.Acta Neuropathologica|December 8, 2023
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisationLucie Auffret, Yassine Ajlil, Arnault Tauziède-Espariat, et al.Proceedings of the National Academy of Sciences of the United States of America|July 13, 2026
Pseudokinase-converting mutation in protein kinase C alpha drives chordoid glioma by pathway rewiringCharlotte Bellamy, Hannah Tovell, Tiffany H Kao, et al.Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.Neurology|September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective StudyAnna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2D Gareth Evans, Michel Kalamarides, Kim Hunter-Schaedle, et al.American Journal of Medical Genetics. Part A|December 6, 2011
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2Jaishri O Blakeley, D Gareth Evans, John Adler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
A Cohort Study of CNS Tumors in Multiple Endocrine Neoplasia Type 1Thomas Graillon, Pauline Romanet, Clara Camilla, et al.Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.Pageof 40